1
|
MacDonald N, Mohsni E, Al-Mazrou Y, Kim Andrus J, Arora N, Elden S, Madrid MY, Martin R, Mahmoud Mustafa A, Rees H, Salisbury D, Zhao Q, Jones I, Steffen CA, Hombach J, O'Brien KL, Cravioto A. Global vaccine action plan lessons learned I: Recommendations for the next decade. Vaccine 2020; 38:5364-5371. [PMID: 32563607 PMCID: PMC7342005 DOI: 10.1016/j.vaccine.2020.05.003] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2020] [Revised: 05/01/2020] [Accepted: 05/02/2020] [Indexed: 12/17/2022]
Abstract
The Global Vaccine Action Plan 2011-2020 (GVAP) was developed to realize the ambitions of the Decade of Vaccines - that all individuals and communities enjoy lives free from vaccine-preventable diseases. It included a comprehensive monitoring and evaluation/accountability framework to assess progress towards global targets with recommendations for corrective actions. While many of the GVAP targets are very unlikely to be met by the end of 2020, substantial progress has nevertheless been made, establishing a strong foundation for a successor global immunization strategy, the Immunization Agenda 2030 (IA2030). The Strategic Advisory Group of Experts on immunization has made a series of recommendations to ensure that the lessons learned from GVAP inform the development and implementation of IA2030.
Collapse
Affiliation(s)
- Noni MacDonald
- SAGE Decade of Vaccines Working Group; Professor of Paediatrics, Dalhousie University, IWK Health Centre, Canada. Chair of the SAGE Decade of Vaccines Working Group.
| | - Ezzeddine Mohsni
- SAGE Decade of Vaccines Working Group; Senior Technical Adviser in Global Health Development/Eastern Mediterranean Public Health Network
| | - Yagob Al-Mazrou
- SAGE Decade of Vaccines Working Group; Secretary General - Health Services Council of the Kingdom of Saudi Arabia, Saudi Arabia
| | - Jon Kim Andrus
- SAGE Decade of Vaccines Working Group; Adjunct Professor and Director, Division of Vaccines and Immunization, Center for Global Health, University of Colorado, USA
| | - Narendra Arora
- SAGE Decade of Vaccines Working Group; Executive director, International Clinical Epidemiology Network, India
| | - Susan Elden
- SAGE Decade of Vaccines Working Group; Health Adviser, Department for International Development, London, UK
| | - Marie-Yvette Madrid
- SAGE Decade of Vaccines Working Group; Independent Consultant, Geneva, Switzerland
| | - Rebecca Martin
- SAGE Decade of Vaccines Working Group; Director of the Center for Global Health, US CDC, USA
| | - Amani Mahmoud Mustafa
- SAGE Decade of Vaccines Working Group; Project Manager, Sudan Public Health Training Initiative, Carter Center, Sudan
| | - Helen Rees
- SAGE Decade of Vaccines Working Group; Executive Director, Wits Reproductive Health and HIV Institute, Personal Professor, Ob/Gyn Codirector, African Leadership in Vaccinology Excellence, University of Witwatersrand, South Africa
| | - David Salisbury
- SAGE Decade of Vaccines Working Group; Associate Fellow, Centre on Global Health Security, Chatham House, London, UK
| | - Qinjian Zhao
- SAGE Decade of Vaccines Working Group; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian, China
| | - Ian Jones
- Jinja Publishing Ltd, Bishop's Stortford, UK
| | - Christoph A Steffen
- Immunization, Vaccines and Biologicals Department, World Health Organization, Geneva, Switzerland
| | - Joachim Hombach
- Immunization, Vaccines and Biologicals Department, World Health Organization, Geneva, Switzerland
| | - Katherine L O'Brien
- Immunization, Vaccines and Biologicals Department, World Health Organization, Geneva, Switzerland
| | - Alejandro Cravioto
- Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico; Chair, Strategic Advisory Group of Experts on Immunization (SAGE)
| |
Collapse
|
2
|
Abstract
Objective: To assess serious prescribing errors, prescribing rate per patient, and ranking of common illnesses and medications prescribed at primary care centers in Saudi Arabia. A proposal for improvement measures will be formulated. Methodology: A cross-sectional study of a randomly selected afternoon shift (4 working h) was carried out on November 1, 1994. All of the 367 physicians working in the health centers in Riyadh, Saudi Arabia participated. All prescriptions issued by physicians during this shift were entered into the study and examined with regard to a number of variables. The variables included patient demographic characteristics, vital signs, the physician's name and center, diagnosis, and prescription items. Demographic variables were excluded from analysis for purposes of confidentiality. Results: During the study period, 11,326 patients were seen, and 6,350 prescriptions were issued (for 20,320 drug entries). The average number of consultations per primary health care (PHC) physician was 30 ± 9. The average number of prescriptions per PHC physician was 17.3 ± 6, for a total of 0.56 prescriptions per patient. Of all prescriptions, 11.6% were found to have at least one error. The average number of drugs per prescription was 3.2 ± 0.4. The average number of drugs per patient was 1.8 ± 0.3. Of all patients, 73% had two or fewer drug items prescribed. Upper respiratory tract infection was the most frequent diagnosis, and accounted for 31.0% of the illnesses seen. Antibiotics, analgesics/antipyretics, and tonics/vitamins were the most common items prescribed (to 16.8%, 15.4%, and 11.8% of the patients, respectively). The most common errors were those considered type B (5.39%), where the pharmacist must contact the physician before dispensing the prescription, and type C (4.59%), where the pharmacist must make a professional decision before dispensing the prescription. Missing drug strength and missing quantity of medication and frequency of dosing were observed in relatively high proportions (3.8% and 3.2%, respectively). Frequency of the daily dose, generic name of the drug, and strength of the drug were the top three missing pieces of information (89.5%, 86%, and 76.3%, respectively). Conclusions: These results represented a challenge and justified setting standards and indicators to ensure the quality of these vital activities of prescribing and dispensing. There is a need to design and implement training programs to improve PHC team prescribing and dispensing skills and establish an accurate system of error reporting.
Collapse
|
3
|
Khalil M, Al-Mazrou Y, Findlow H, Chadha H, Bosch Castells V, Oster P, Borrow R. Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine. Vaccine 2014; 32:5715-21. [PMID: 25151042 DOI: 10.1016/j.vaccine.2014.08.026] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2014] [Revised: 06/30/2014] [Accepted: 08/08/2014] [Indexed: 10/24/2022]
Abstract
Following repeated polysaccharide vaccination, reduced immune responses have been reported, but there are limited data on the mucosal response of meningococcal polysaccharide vaccine (PSV) or meningococcal conjugate vaccination. Saudi Arabian adolescents (aged 16-19 years) who had previously been vaccinated with ≥1 dose of bivalent meningococcal polysaccharide vaccine and 1 dose of quadrivalent meningococcal polysaccharide (MPSV4) were enrolled in a controlled, randomised, and modified observer-blind study (collectively termed the PSV-exposed group). The PSV-exposed group was randomised to receive either quadrivalent meningococcal conjugate vaccine (MCV4) (PSV-exposed/MCV4 group) or MPSV4 (PSV-exposed/MPSV4 group), and a PSV-naïve group received MCV4. Serum and saliva samples were collected pre-vaccination and 28 days post-vaccination. Serum serogroup-specific A, C, W and Y IgG were quantified as were salivary serogroup-specific C IgG and IgA together with total salivary IgG and IgA. For each serogroup, the post-vaccination serum geometric mean concentrations (GMCs) were significantly higher in the PSV-naïve and the PSV-exposed/MCV4 group than in the PSV-exposed/PSV4 group. For serogroup C, serum serogroup-specific IgG for the PSV-naïve group was significantly higher than both the PSV exposed groups. Higher levels of salivary serogroup C-specific IgG were found in the PSV-naïve group than those who had received two doses of polysaccharide but no significant differences were noted with regards to serogroup-specific IgA.
Collapse
Affiliation(s)
| | | | - Helen Findlow
- Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UK
| | - Helen Chadha
- Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UK
| | | | | | - Ray Borrow
- Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UK; University of Manchester, Inflammation Sciences Research Group, School of Translational Medicine, Stopford Building, Manchester, UK.
| |
Collapse
|
4
|
Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, Farnot U, Bergsjø P, Bakketeig L, Lumbiganon P, Campodónico L, Al-Mazrou Y, Lindheimer M, Kramer M. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006; 194:921-31. [PMID: 16580277 DOI: 10.1016/j.ajog.2005.10.813] [Citation(s) in RCA: 313] [Impact Index Per Article: 17.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2005] [Revised: 09/12/2005] [Accepted: 10/27/2005] [Indexed: 12/14/2022]
Abstract
OBJECTIVE Preeclampsia, gestational hypertension, and unexplained intrauterine growth restriction may have similar determinants and consequences. In this study, we compared determinants and perinatal outcomes associated with these obstetric conditions. STUDY DESIGN We analyzed 39,615 pregnancies (data from the WHO Antenatal Care Trial), of which 2.2% were complicated by preeclampsia, 7.0% by gestational hypertension, and 8.1% by unexplained intrauterine growth restriction (ie, not associated with maternal smoking, maternal undernutrition, preeclampsia, gestational hypertension, or congenital malformations). We compared the risk factors associated with these groups. Fetal death, preterm delivery, and severe neonatal morbidity and mortality were the primary outcomes. Logistic regression analyses were adjusted for study site, socioeconomic status, and (if appropriate) birth weight and gestational age. RESULTS Diabetes, renal or cardiac disease, previous preeclampsia, urinary tract infection, high maternal age, twin pregnancy, and obesity increased the risk of both hypertensive conditions. Previous large-for-age birth, reproductive tract surgery, antepartum hemorrhage and reproductive tract infection increased the risk for gestational hypertension only. Independent of maternal age, primiparity was a risk factor only for preeclampsia. Both preeclampsia and gestational hypertension were associated with increased risk for fetal death and severe neonatal morbidity and mortality. Mothers with preeclampsia compared with those with unexplained intrauterine growth restriction were more likely to have a history of diabetes, renal or cardiac disease, chronic hypertension, previous preeclampsia, body mass index more than 30 kg/cm2, urinary tract infection and extremes of maternal age. Conversely, unexplained intrauterine growth restriction was associated with higher risk of low birth weight in previous pregnancies, but not with previous preeclampsia. Both conditions increased the risk for perinatal outcomes independently but preeclampsia was associated with considerable higher risk. CONCLUSION Preeclampsia and gestational hypertension shared many risk factors, although there are differences that need further evaluation. Both conditions significantly increased morbidity and mortality. Conversely, preeclampsia and unexplained intrauterine growth restriction, often assumed to be related to placental insufficiency, seem to be independent biologic entities.
Collapse
Affiliation(s)
- José Villar
- United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Program of Research, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Khalil M, Al-Mazrou Y, Balmer P, Bramwell J, Andrews N, Borrow R. Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age. Clin Diagn Lab Immunol 2005; 12:1251-3. [PMID: 16210493 PMCID: PMC1247841 DOI: 10.1128/cdli.12.10.1251-1253.2005] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Meningococcal tetravalent polysaccharide vaccines were observed to be immunogenic in Saudi children 5 to 9 years of age, with >90% having serum bactericidal antibody titers of > or = 8 for serogroups A, Y, and W135; for serogroup C, 77% were putatively protected after vaccination.
Collapse
Affiliation(s)
- M Khalil
- Medical Education and Research Center, King Fahad Specialist Hospital, Qassim, Saudi Arabia
| | | | | | | | | | | |
Collapse
|
6
|
Al-Mazrou Y, Khalil M, Borrow R, Balmer P, Bramwell J, Lal G, Andrews N, Al-Jeffri M. Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age. Infect Immun 2005; 73:2932-9. [PMID: 15845499 PMCID: PMC1087384 DOI: 10.1128/iai.73.5.2932-2939.2005] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2004] [Revised: 01/05/2005] [Accepted: 01/09/2005] [Indexed: 11/20/2022] Open
Abstract
An immunization campaign with meningococcal ACYW135 polysaccharide vaccine was conducted in 2003 by the Saudi Arabian Ministry of Health and included a study to evaluate the immune responses in children under 5 years of age in the Al Qassim region of Saudi Arabia. Children who were >/=24 months old were given one dose of tetravalent polysaccharide vaccine, while younger children were given two doses with an interval of 2 to 3 months. Blood samples were collected prevaccination and 1 month after the second dose for children younger than 24 months old and 1 month after the single dose for older children. Serogroup-specific antibody responses were determined by serum bactericidal antibody (SBA) assays and a tetraplex immunoglobulin G (IgG) bead assay. Significant increases in the proportions of individuals who were >/=24 months old with SBA titers of >/=8 were observed pre- to postvaccination for all serogroups. Age-dependent increases in the percentage of individuals with SBA titers of >/=8 1 month postvaccination were observed for each serogroup. Age-dependent increases in postvaccination IgG levels were observed for serogroup A (menA), serogroup W135 (menW), and serogroup Y (menY) but not for serogroup C (menC). Two doses of tetravalent polysaccharide vaccine in individuals who were =18 months old were poorly immunogenic for menC, menW, and menY. However, for menA, 42% of the children who were 18 months old were putatively protected with SBA titers of >/=8. A high percentage of subjects who were >/=2 years of age were putatively protected for menA; a similar level was observed for menY for children who were 4 years of age but not for younger children. However, for menC and menW poor levels of putative protection were still evident at 4 years of age.
Collapse
Affiliation(s)
- Y Al-Mazrou
- Meningococcal Reference Unit, HPA North West Laboratory, Manchester Royal Infirmary, Manchester, United Kingdom
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Villar J, Abalos E, Carroli G, Giordano D, Wojdyla D, Piaggio G, Campodonico L, Gülmezoglu M, Lumbiganon P, Bergsjø P, Ba'aqeel H, Farnot U, Bakketeig L, Al-Mazrou Y, Kramer M. Heterogeneity of Perinatal Outcomes in the Preterm Delivery Syndrome. Obstet Gynecol 2004; 104:78-87. [PMID: 15229004 DOI: 10.1097/01.aog.0000130837.57743.7b] [Citation(s) in RCA: 64] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE Our aim was to document the differential neonatal morbidity and intrapartum and neonatal mortality of subgroups of preterm delivery. METHODS This analysis included 38,319 singleton pregnancies, of which 3,304 (8.6%) were preterm deliveries (less than 37 completed weeks) enrolled in the World Health Organization randomized trial of a new antenatal care model. We classified them as preterm deliveries after spontaneous initiation of labor, either with or without maternal obstetric and medical complications; preterm deliveries after prelabor spontaneous rupture of amniotic membranes (PROM), either with or without obstetric and medical complications; and medically indicated preterm deliveries with maternal obstetric and medical complications. Severe neonatal morbidity and neonatal mortality were the primary outcomes. RESULTS Fifty-six percent of all preterm deliveries were spontaneous, without maternal complications. Small for gestational age was increased only among the medically indicated preterm delivery group (22.3%). Very early preterm delivery (less than 32 weeks of gestation) was highest among PROM with complications (37%). For intrapartum fetal death and neonatal death, after adjusting by gestational age and other confounding variables, we found that the obstetric and medical complications preceding preterm delivery predicted the different risk levels. Conversely, for severe neonatal morbidity the clinical presentation, ie, PROM or medically indicated, predicted the increased risk. CONCLUSION There are differential neonatal outcomes among preterm deliveries according to clinical presentation, pregnancy complications, gestational age at delivery, and its association with small for gestational age. This syndromic nature of the condition should be considered if preterm delivery is to be fully understood and thus reduced.
Collapse
Affiliation(s)
- José Villar
- World Health Organization/World Bank Special Program of Research, Development, and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Nigenda G, Langer A, Kuchaisit C, Romero M, Rojas G, Al-Osimy M, Villar J, Garcia J, Al-Mazrou Y, Ba'aqeel H, Carroli G, Farnot U, Lumbiganon P, Belizán J, Bergsjo P, Bakketeig L, Lindmark G. Womens' opinions on antenatal care in developing countries: results of a study in Cuba, Thailand, Saudi Arabia and Argentina. BMC Public Health 2003; 3:17. [PMID: 12756055 PMCID: PMC166129 DOI: 10.1186/1471-2458-3-17] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2002] [Accepted: 05/20/2003] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The results of a qualitative study carried out in four developing countries (Cuba, Thailand, Saudi Arabia and Argentina) are presented. The study was conducted in the context of a randomised controlled trial to test the benefits of a new antenatal care protocol that reduced the number of visits to the doctor, rationalised the application of technology, and improved the provision of information to women in relation to the traditional protocol applied in each country. METHODS Through focus groups discussions we were able to assess the concepts and expectations underlying women's evaluation of concepts and experiences of the care received in antenatal care clinics. 164 women participated in 24 focus groups discussion in all countries. RESULTS Three areas are particularly addressed in this paper: a) concepts about pregnancy and health care, b) experience with health services and health providers, and c) opinions about the modified Antenatal Care (ANC) programme. In all three topics similarities were identified as well as particular opinions related to country specific social and cultural values. In general women have a positive view of the new ANC protocol, particularly regarding the information they receive. However, controversial issues emerged such as the reduction in the number of visits, particularly in Cuba where women are used to have 18 ANC visits in one pregnancy period. CONCLUSION Recommendations to improve ANC services performance are being proposed. Any country interested in the application of a new ANC protocol should regard the opinion and acceptability of women towards changes.
Collapse
Affiliation(s)
| | - Ana Langer
- Regional Office for Latin America and the Caribbean, The Population Council. Mexico City, Mexico
| | | | - Mariana Romero
- Centro Rosarino de Estudios Perinatales, Rosario / Centro de Estudios de Estado y Sociedad-CONICET, Buenos Aires, Argentina
| | - Georgina Rojas
- Hospital Gineco-Obstétrico 'América Arias', Havana, Havana, Cuba
| | | | - José Villar
- Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland
| | - Jo Garcia
- National Perinatal Epidemiology Unit, Oxford University, Oxford, England
| | | | | | | | - Ubaldo Farnot
- Hospital Gineco-Obstétrico 'América Arias', Havana, Havana, Cuba
| | | | - José Belizán
- Latin American Centre for Perinatology and Human Development, Montevideo, Uruguay
| | - Per Bergsjo
- Department of Obstetrics and Gynecology, Oslo, Norway, University of Bergen, Bergen, Norway
| | - Leiv Bakketeig
- Department of Obstetrics and Gynecology, University of Bergen, Bergen, Norway
| | - Gunilla Lindmark
- Department of Obstetrics and Gynecology, University Hospital, Uppsala, Sweden
| |
Collapse
|
9
|
Godsey MS, Abdoon AMM, Savage HM, Al-Sharani AM, Al-Mazrou Y, Al-Jeffri MH, Al-Sughair S, Al-Safi S, Ksiazek TG, Miller BR. First record of Aedes (Stegomyia) unilineatus in the Kingdom of Saudi Arabia. J Am Mosq Control Assoc 2003; 19:84-86. [PMID: 12674542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Entomological surveillance was conducted in Asir, Jizan, and Makkah regions, Kingdom of Saudi Arabia, during December 2000 in response to an outbreak of Rift Valley fever. Aedes (Stegomyia) unilineatus was collected in CO2-baited Centers for Disease Control miniature light traps at 4 widely spaced sites. This represents the 1st record of this species from the Arabian Peninsula. Previously, the distribution of Ae. unilineatus included Africa, Pakistan, and India. No arboviruses were isolated from 18 females tested by Vero cell plaque assay.
Collapse
Affiliation(s)
- Marvin S Godsey
- Arbovirus Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, PO Box 2087, Fort Collins, CO 80522, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Al-Mazrou Y, Tumsah S, Khalil M, Al-Jeffri M, Afzal MA, al-Ghamdy Y, Mishkhas A, Essa M. Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia. J Trop Pediatr 2002; 48:354-8. [PMID: 12521278 DOI: 10.1093/tropej/48.6.354] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Monitoring of adverse events following the administration of MMR vaccine containing the Urabe mumps virus vaccine strain, to over 2 million schoolchildren (aged 6-13 years) revealed that the incidence of vaccine-associated aseptic meningitis was one case per 295 000 doses given. About 92 per cent of these children had had their primary immunization against MMR at 12 months of age and, therefore, were probably not immunologically naïve. It appears from our data that the use of the Urabe-based mumps vaccine in the booster-dose format induces much less adverse effects than usually observed following the primary immunization with it. Further studies are needed to prove this conclusively.
Collapse
|
11
|
Langer A, Villar J, Romero M, Nigenda G, Piaggio G, Kuchaisit C, Rojas G, Al-Osimi M, Miguel Belizán J, Farnot U, Al-Mazrou Y, Carroli G, Ba'aqeel H, Lumbiganon P, Pinol A, Bergsjö P, Bakketeig L, Garcia J, Berendes H. Are women and providers satisfied with antenatal care? Views on a standard and a simplified, evidence-based model of care in four developing countries. BMC Womens Health 2002; 2:7. [PMID: 12133195 PMCID: PMC122068 DOI: 10.1186/1472-6874-2-7] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2002] [Accepted: 07/19/2002] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND: This study assessed women and providers' satisfaction with a new evidence-based antenatal care (ANC) model within the WHO randomized trial conducted in four developing countries. The WHO study was a randomized controlled trial that compared a new ANC model with the standard type offered in each country. The new model of ANC emphasized actions known to be effective in improving maternal or neonatal health, excluded other interventions that have not proved to be beneficial, and improved the information component, especially alerting pregnant women to potential health problems and instructing them on appropriate responses. These activities were distributed within four antenatal care visits for women that did not need any further assessment. METHODS: Satisfaction was measured through a standardized questionnaire administered to a random sample of 1,600 pregnant women and another to all antenatal care providers. RESULTS: Most women in both arms expressed satisfaction with ANC. More women in the intervention arm were satisfied with information on labor, delivery, family planning, pregnancy complications and emergency procedures. More providers in the experimental clinics were worried about visit spacing, but more satisfied with the time spent and information provided. CONCLUSIONS: Women and providers accepted the new ANC model generally. The safety of fewer visits for women without complications with longer spacing would have to be reinforced, if such a model is to be introduced into routine practice.
Collapse
Affiliation(s)
- Ana Langer
- Regional Office for Latin America and the Caribbean, The Population Council, Mexico City, Mexico
| | - José Villar
- Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland
| | - Mariana Romero
- Centro Rosarino de Estudios Perinatales, Rosario, Argentina
| | | | - Gilda Piaggio
- Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland
| | | | - Georgina Rojas
- Hospital Gineco-Obstétrico "América Arias", Havana, Cuba
| | - Muneera Al-Osimi
- Latin American Centre for Perinatology and Human Development, Montevideo, Uruguay
| | - José Miguel Belizán
- Latin American Centre for Perinatology and Human Development, Montevideo, Uruguay
| | - Ubaldo Farnot
- Hospital Gineco-Obstétrico "América Arias", Havana, Cuba
| | | | | | | | | | - Alain Pinol
- Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland
| | - Per Bergsjö
- Department of Obstetrics and Gynaecology, University of Bergen, Bergen, Norway
| | | | - Jo Garcia
- National Perinatal Epidemiology Unit, Oxford University, Oxford, England
| | - Heinz Berendes
- National Institute of Child Health and Human Development. Bethesda, Maryland, USA
| |
Collapse
|
12
|
Lumbiganon P, Piaggio G, Villar J, Pinol A, Bakketeig L, Bergsjo P, Al-Mazrou Y, Ba'aqeel H, Belizán JM, Farnot U, Carroli G, Berendes H. The epidemiology of syphilis in pregnancy. Int J STD AIDS 2002; 13:486-94. [PMID: 12171669 DOI: 10.1258/09564620260079653] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
This study evaluated the magnitude, risk factors and outcomes of syphilis in pregnancy in a large cohort of women in four countries participating in the World Health Organization (WHO) antenatal care trial. All women attending the first prenatal care at each selected clinic were enrolled. Screening at the first antenatal visit was routinely performed with either rapid plasma reagin or Venereal Disease Research Laboratory and confirmed by fluorescent treponemal antibody absorption. All women also had the same syphilis tests after delivery. The initial prevalence, the incidence during pregnancy and the overall prevalence of syphilis at delivery were 0.9%, 0.4% and 1.3% respectively. Risk factors for syphilis during pregnancy were younger age for the incidence and older age and a history of stillbirth for the prevalence. Women with syphilis during pregnancy had significantly more adverse outcomes. We support the recommendation that in addition to the initial testing, a second routine test for syphilis ought to be established early in the third trimester even in low prevalence areas.
Collapse
Affiliation(s)
- P Lumbiganon
- Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Villar J, Ba'aqeel H, Piaggio G, Lumbiganon P, Miguel Belizán J, Farnot U, Al-Mazrou Y, Carroli G, Pinol A, Donner A, Langer A, Nigenda G, Mugford M, Fox-Rushby J, Hutton G, Bergsjø P, Bakketeig L, Berendes H, Garcia J. WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet 2001. [PMID: 11377642 DOI: 10.1016/s014-6736(00)04722-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 09/30/2022]
Abstract
BACKGROUND We undertook a multicentre randomised controlled trial that compared the standard model of antenatal care with a new model that emphasises actions known to be effective in improving maternal or neonatal outcomes and has fewer clinic visits. METHODS Clinics in Argentina, Cuba, Saudi Arabia, and Thailand were randomly allocated to provide either the new model (27 clinics) or the standard model currently in use (26 clinics). All women presenting for antenatal care at these clinics over an average of 18 months were enrolled. Women enrolled in clinics offering the new model were classified on the basis of history of obstetric and clinical conditions. Those who did not require further specific assessment or treatment were offered the basic component of the new model, and those deemed at higher risk received the usual care for their conditions; however, all were included in the new-model group for the analyses, which were by intention to treat. The primary outcomes were low birthweight (<2500 g), pre-eclampsia/eclampsia, severe postpartum anaemia (<90 g/L haemoglobin), and treated urinary-tract infection. There was an assessment of quality of care and an economic evaluation. FINDINGS Women attending clinics assigned the new model (n=12568) had a median of five visits compared with eight within the standard model (n=11958). More women in the new model than in the standard model were referred to higher levels of care (13.4% vs 7.3%), but rates of hospital admission, diagnosis, and length of stay were similar. The groups had similar rates of low birthweight (new model 7.68% vs standard model 7.14%; stratified rate difference 0.96 [95% CI -0.01 to 1.92]), postpartum anaemia (7.59% vs 8.67%; 0.32), and urinary-tract infection (5.95% vs 7.41%; -0.42 [-1.65 to 0.80]). For pre-eclampsia/eclampsia the rate was slightly higher in the new model (1.69% vs 1.38%; 0.21 [-0.25 to 0.67]). Adjustment by several confounding variables did not modify this pattern. There were negligible differences between groups for several secondary outcomes. Women and providers in both groups were, in general, satisfied with the care received, although some women assigned the new model expressed concern about the timing of visits. There was no cost increase, and in some settings the new model decreased cost. INTERPRETATIONS Provision of routine antenatal care by the new model seems not to affect maternal and perinatal outcomes. It could be implemented without major resistance from women and providers and may reduce cost.
Collapse
Affiliation(s)
- J Villar
- UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development, and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organisation, Geneva, Switzerland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Villar J, Ba'aqeel H, Piaggio G, Lumbiganon P, Miguel Belizán J, Farnot U, Al-Mazrou Y, Carroli G, Pinol A, Donner A, Langer A, Nigenda G, Mugford M, Fox-Rushby J, Hutton G, Bergsjø P, Bakketeig L, Berendes H, Garcia J. WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet 2001; 357:1551-64. [PMID: 11377642 DOI: 10.1016/s0140-6736(00)04722-x] [Citation(s) in RCA: 364] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
BACKGROUND We undertook a multicentre randomised controlled trial that compared the standard model of antenatal care with a new model that emphasises actions known to be effective in improving maternal or neonatal outcomes and has fewer clinic visits. METHODS Clinics in Argentina, Cuba, Saudi Arabia, and Thailand were randomly allocated to provide either the new model (27 clinics) or the standard model currently in use (26 clinics). All women presenting for antenatal care at these clinics over an average of 18 months were enrolled. Women enrolled in clinics offering the new model were classified on the basis of history of obstetric and clinical conditions. Those who did not require further specific assessment or treatment were offered the basic component of the new model, and those deemed at higher risk received the usual care for their conditions; however, all were included in the new-model group for the analyses, which were by intention to treat. The primary outcomes were low birthweight (<2500 g), pre-eclampsia/eclampsia, severe postpartum anaemia (<90 g/L haemoglobin), and treated urinary-tract infection. There was an assessment of quality of care and an economic evaluation. FINDINGS Women attending clinics assigned the new model (n=12568) had a median of five visits compared with eight within the standard model (n=11958). More women in the new model than in the standard model were referred to higher levels of care (13.4% vs 7.3%), but rates of hospital admission, diagnosis, and length of stay were similar. The groups had similar rates of low birthweight (new model 7.68% vs standard model 7.14%; stratified rate difference 0.96 [95% CI -0.01 to 1.92]), postpartum anaemia (7.59% vs 8.67%; 0.32), and urinary-tract infection (5.95% vs 7.41%; -0.42 [-1.65 to 0.80]). For pre-eclampsia/eclampsia the rate was slightly higher in the new model (1.69% vs 1.38%; 0.21 [-0.25 to 0.67]). Adjustment by several confounding variables did not modify this pattern. There were negligible differences between groups for several secondary outcomes. Women and providers in both groups were, in general, satisfied with the care received, although some women assigned the new model expressed concern about the timing of visits. There was no cost increase, and in some settings the new model decreased cost. INTERPRETATIONS Provision of routine antenatal care by the new model seems not to affect maternal and perinatal outcomes. It could be implemented without major resistance from women and providers and may reduce cost.
Collapse
Affiliation(s)
- J Villar
- UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development, and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organisation, Geneva, Switzerland.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Piaggio G, Carroli G, Villar J, Pinol A, Bakketeig L, Lumbiganon P, Bergsjø P, Al-Mazrou Y, Ba'aqeel H, Belizán JM, Farnot U, Berendes H. Methodological considerations on the design and analysis of an equivalence stratified cluster randomization trial. Stat Med 2001; 20:401-16. [PMID: 11180310 DOI: 10.1002/1097-0258(20010215)20:3<401::aid-sim801>3.0.co;2-1] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The World Health Organization and collaborating institutions in four developing countries have conducted a multi-centre randomized controlled trial, in which clinics were allocated at random to two antenatal care (ANC) models. These were the standard 'Western' ANC model and a 'new' ANC model consisting of tests, clinical procedures and follow-up actions scientifically demonstrated to be effective in improving maternal and newborn outcomes. The two models were compared using the equivalence approach. This paper discusses the implications of the equivalence approach in the sample size calculation, analysis and interpretation of results of this cluster randomized trial. It reviews the ethical aspects regarding informed consent, concluding that the Zelen design has a place in cluster randomization trials. It describes the estimation of the intracluster correlation coefficient (ICC) in a stratified cluster randomized trial using two methods and reports estimates of the ICC obtained for many maternal, newborn and perinatal outcomes. Finally, it discusses analytical problems that arose: issues encountered using a composite index, heterogeneity of the intervention effect across sites, the choice of the method of analysis and the importance of efficacy analyses. The choice of the clustered Woolf estimator and the generalized estimating equations (GEE) as the methods of analysis applied is discussed.
Collapse
Affiliation(s)
- G Piaggio
- Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Abstract
BACKGROUND Saudi children vaccinated with a primary series of Hib vaccine (HbOC) at six weeks, three and five months have shown higher antibody titers compared to recent data from the U.S. The aim of this study was to evaluate the persistence of antibodies and to measure the immunogenicity of a booster dose of Haemophilus influenzae type b (Hib) vaccine in Saudi children. PATIENTS AND METHODS In the first phase of the trial, 210 children were divided into three groups. Group 1 received HbOC, DPT and the WHO formula of oral poliovirus vaccine (OPV); group 2 received HbOC, DPT and the FDA formula of OPV; and group 3 (control) received DPT and the WHO formula of OPV, without HbOC. Haemophilus influenzae geometric mean antibody levels after primary immunization were reported previously. In this study, blood samples were collected at 18 months (before the booster dose) and one month later to measure antibody levels against Haemophilus influenzae polysaccharide. RESULTS Following the booster doses, there was an increase in the geometric mean titers (GMTs) from 2.57 microg/mL to 39.4 microg/mL in group 1, and from 1.2 microg/mL to 48.9 microg/mL in group 2. In group 3, the GMT remained at 0.3 microg/mL. There was no significant difference in Hib GMTs after the booster dose between children given Hib vaccine with the FDA formula of DPT and OPV and those given the WHO formula. CONCLUSION Based on the high immunogenicity of the Hib vaccine in Saudi children, a booster dose is not necessary at the initial stages of immunization, and should instead be given to children in the second year of life. This option, however, needs further evaluation and close monitoring.
Collapse
Affiliation(s)
- M Khalil
- Ministry of Health, Riyadh, Saudi Arabia
| | | | | | | | | |
Collapse
|
17
|
Khalil M, Al-Mazrou Y, Al-Howasi M, Al-Jeffri M. Immunogenicity of FDA DTP versus WHO DTP. Ann Saudi Med 1999; 19:417-9. [PMID: 17277507 DOI: 10.5144/0256-4947.1999.417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND The aim of this report was to study the immunogenicity of three doses of DTP in six-week-old Saudi infants when given either as World Health Organization (WHO) DTP or Federal Drug Administration (FDA) DTP formula. METHODS As part of the Haemophilus influenzae type b immunization research protocol, six-week-old infants were randomized into three groups to receive three doses of HbOC and WHO DTP formula, HbOC and FDA DTP formula, or in a control group to receive the usual vaccines without HbOC, at six weeks, three months and five months. Antibody levels for PRP, tetanus, diphtheria and pertussis were measured after the third dose. The results of diphtheria, pertussis and tetanus are presented in this paper. RESULTS After three doses, no difference was found between anti-PRP when given with either FDA DTP or WHO DTP formula. Also anti-tetanus and anti-diphtheria antibodies were significantly higher in the group vaccinated with HbOC and FDA DTP formula, compared to children vaccinated with WHO DTP formula. No negative interactions with other vaccines were observed after the third dose. Conclusion. Although diphtheria and tetanus antigens in the FDA formula are half the concentration in the WHO formula, they are more antigenic. There is a need for methods of potency assay to be re-evaluated.
Collapse
Affiliation(s)
- M Khalil
- STAT Advisory Medical Center for Research Development, Cairo, Egypt, and Ministry of Health, Riyadh, Saudi Arabia
| | | | | | | |
Collapse
|
18
|
Al-Nuaim AR, Mirdad S, Al-Rubeaan K, Al-Mazrou Y, Al-Attas O, Al-Daghari N. Pattern and factors associated with glycemic control of Saudi diabetic patients. Ann Saudi Med 1998; 18:109-12. [PMID: 17341938 DOI: 10.5144/0256-4947.1998.109] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND The pattern and factors which can be associated with the glycemic control of Saudi adult diabetic patients were examined in this study. PATIENTS AND METHODS Confirmed diabetic patients from all regions of Saudi Arabia constituted the study population. Random blood glucose <10 mmol/L and >10 mmol/L was used to categorize patients into good and poor glycemic control patients, respectively. RESULTS There were 613 confirmed non-insulin dependent diabetic patients (NIDDM), 50% with good glycemic control. Patients with poor glycemic control were significantly older than patients with good glycemic control (51.5 vs. 47 years, P=0.0001). The insulin-treated diabetic population amounted to 13%, compared with 43% and 44% for oral agent and diet, respectively. The rate of insulin users among poor glycemic control diabetic population was 18%, compared with 50% for oral agents. There was a significant relationship between glycemic control and age, and treatment modalities of DM. Subjects who had good glycemic control of DM were younger and following a diet regimen, while those who had poor glycemic control were older and on insulin treatment. Multivariate analysis comprising 415 individuals was conducted to find out the factors that can potentially influence, or may be associated with, the control of DM. CONCLUSION The association of insulin therapy with poor glycemic control is not a cause-effect relationship. Insulin therapy in our study population is underutilized, given the high rate of poor glycemic control and high rate of relative occurrence of complication among the Saudi diabetic population. There is a need to address the importance of maintaining good glycemic control, and the reason for the low rate of insulin users. Close periodic monitoring of glycemic control, utilizing laboratories and home glucose monitoring devices, is required. Effective implementation of these measures, in addition to diabetes education, will have an impact on the future outcome of the Saudi diabetic population.
Collapse
Affiliation(s)
- A R Al-Nuaim
- Department of Medicine, King Khalid University Hospital, Department of Biochemistry, King Saud University, and Department of Preventive Medicine, Ministry of Health, Riyadh, Saudi Arabia
| | | | | | | | | | | |
Collapse
|
19
|
Abstract
The prevalence of anti-HAV antibody in children was tested in subjects presenting at clinics in Riyadh, Saudi Arabia. A blood sample was taken to test for the presence of IgG (indicating past infection) and a questionnaire concerning personal and epidemiological data relating to hepatitis A was completed. In total, 592 children aged 6 months to 15 years were suitable for the analysis. There were 179 subjects who were positive for HAV (30.2%). The proportions of subjects positive for HAV varied significantly with age (P=0.001); 32%-49% in the 7-15 age range were positive compared with 13-20% aged 6 and below. There was a significant association between a positive HAV test and social level (P=0.044), with a higher proportion positive in the low social level. Children with jaundice, personal history of jaundice or travel abroad were significantly more likely to be HAV positive (P=0.001, P=0.006, P=0.021, respectively). There was also a significant association with nationality (P=0.022), where the lowest proportion of HAV positive children were Saudi Arabian (28%). Compared to previous studies, there is a significant decrease in the HAV exposure in Saudi children with shift from high to intermediate pattern. National strategy for prevention should be evaluated.
Collapse
Affiliation(s)
- M Khalil
- Departments of Preventive Medicine and Infectious Diseases, Ministry of Health, Saudi Arabia
| | | | | | | |
Collapse
|
20
|
Al-Sulaiman A, Al-Mazrou Y, Al-Jeffry M, Jamjoom G, Al-Hawas M, Mishkas A, Al-Mazrou A, Makki O, Al-Ahadal M. Did the national campaign for poliomyelitis vaccination achieve its objectives. Saudi Med J 1998; 19:13-14. [PMID: 27701506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023] Open
Abstract
Full text is available as a scanned copy of the original print version.
Collapse
Affiliation(s)
- Abdulsalam Al-Sulaiman
- Department of Neurology, King Fahd Hospital of the University, Al-Khobar, Kingdom of Saudi Arabia
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Al-Faris E, Al-Subaie A, Khoja T, Al-Ansary L, Abdul-Raheem F, Al-Hamdan N, Al-Mazrou Y, Abdul-Moneim H, El Khwsky F. Training primary health care physicians in Saudi Arabia to recognize psychiatric illness. Acta Psychiatr Scand 1997; 96:439-44. [PMID: 9421340 DOI: 10.1111/j.1600-0447.1997.tb09945.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
In order to evaluate the effect of training primary health care (PHC) physicians to recognize mental disorders, an intervention randomized controlled trial was conducted. Three categories of PHC physicians were selected: the index group (n = 12 doctors), control group 1 (n = 12) and control group 2 (n = 4). For 1 week randomly selected patients from all trial centres were asked to complete the General Health Questionnaire (GHQ-28), and the three groups of doctors were asked to identify the presence of and rate the severity of any mental disorder in these patients. The same process was repeated for all three groups after a 6-month training course which was provided for the index group only. The doctors' ability to detect mental disorders was measured by calculating Spearman's correlation coefficient between their severity rating and the GHQ scores of their patients. Training produced a noticeable improvement in the diagnostic accuracy of the index group, whereas there was minimal improvement in control group 1 and deterioration in control group 2. Recommendations to improve the ability of PHC physicians to detect mental disorders are discussed.
Collapse
Affiliation(s)
- E Al-Faris
- Department of Family and Community Medicine, King Saud University, Riyadh, Saudi Arabia
| | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Abstract
Data on the status of iodine deficiency in the Arabian peninsula is scarce. We have conducted a cross-sectional national epidemiological survey in Saudi Arabia to study the iodine status of Saudi schoolchildren, between eight and ten years, who were randomly selected, after taking into consideration the gender, provincial population and area distribution. Casual urine samples were collected and sent to the central laboratory for analysis. Clinical assessment for the presence of goiter was conducted in four areas with different geographical natures. The survey included 4638 subjects, and their median and mean (SD) of urinary iodine concentration was 18 and 17 m g/dL, respectively. We found provincial differences with respect to urinary iodine concentration and the percentage of subjects with urinary iodine concentration <10 m g/dL. The Southern province had the lowest median (11 m g/dL) and the highest percentage (45%) of subjects with urinary iodine concentration <10 m g/dL. On the other hand, subjects of the Western province had the highest median (24 m g/dL) and the lowest percentage (8%) of subjects with urinary iodine concentration <10 m g/dL. The clinical assessment revealed that the highest prevalence and more advanced grade of goiter (22%, 95% CI 19-25, grade 1; 8%, 95% CI 6-10, grade 2) was found in the Asir region, a high-altitude area in the Southern province. The lowest prevalence of goiter (4%, 95% CI 0.8-7.2, grade 1) was found in Gizan, an urban coastal community. There was a significant relationship between the prevalence of goiter and the urinary iodine concentration. The survey for iodine deficiency disorder (IDD) in Saudi Arabia has shown a mild degree of iodine deficiency in the Southern province. Odds ratio (OR) was used to study the statistical relationship between the prevalence of goiter and the urinary iodine concentration. There is a need to launch a control program to ensure the exclusive availability of iodized salt in Saudi Arabia, especially in the Southern province.
Collapse
Affiliation(s)
- A R Al-Nuaim
- Department of Medicine, and College of Science, King Saud University, Ministry of Health, and Department of Medicine, Security Forces Hospital, Riyadh, Saudi Arabia
| | | | | | | | | | | |
Collapse
|
23
|
Al-Nuaim AR, Al-Rebeann K, Al-Mazrou Y, Al-Attas O, Al-Daghari N. Serum total, fractionated cholesterol concentration distribution and prevalence of hypercholesterolemia in Saudi Arabia, regional variation. Ann Saudi Med 1997; 17:179-84. [PMID: 17377426 DOI: 10.5144/0256-4947.1997.179] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
This is a study of the regional variation in Saudi Arabia with respect to the pattern of distribution of total serum cholesterol concentration, low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol to HDL ratio (CH/HDL) and prevalence of hypercholesterolemia (HC) among Saudi population. It is a cross-sectional national epidemiological randomized household survey. The subjects consisted of 4548 Saudis over the age of 15 years. The sample was representative and in accordance with the national population distribution with respect to age, gender, regional and residency population distribution. Blood samples were drawn and assayed for total cholesterol concentration (TCC), triglyceride and high-density lipoprotein concentration. Low- density lipoprotein and total cholesterol/high-density lipoprotein ratio were calculated. The mean serum TCC of female subjects was higher than for male subjects across all regions; however, the difference reached a significance only in the Southern and Western regions. The 90th percentile of serum TCC for male subjects was either equal to or higher than that for female subjects at early age groups across all regions; however, the 90th percentile of serum TCC for female subjects was higher than for male subjects at older age groups across all regions. Mean serum HDL concentration for female subjects was either equal to or higher than for male subjects across all regions, except the Central region. The difference, however, reached a significance in the Western region only. The prevalence of borderline high HC (5.2 to 6.2 mmol/L) was higher among male subjects in the Central region and equal between male and female subjects of Western and Eastern regions and higher among female subjects in the Northern and Southern regions. The prevalence of high HC (>6.2 mmol/L) was higher among female subjects compared with male subjects across all regions. The highest and lowest prevalence of high HC among male subjects in the Eastern and Northern regions, respectively, while the highest and lowest prevalence of high HC among female subjects were in the Eastern and Northern regions. The prevalence of HC (>5.2 mmol/L) among subjects over the age of 40 years was highest and lowest for male subjects of Eastern and Southern regions, respectively, and for female subjects of Eastern and Western regions, respectively. There was a variable pattern of serum total and fractionated cholesterol concentration distribution among Saudi subjects. It appears, however, that at large, the subjects of the Eastern and Northern regions had the highest and lowest prevalences of cholesterol-related risk factors for CVD, respectively. There is a need to study the underlying factors for the regional variation with respect to cholesterol-related risk factors with emphasis on nutritional habits, including the quantity and quality of food, the prevalence of obesity, glucose intolerance and smoking. Identification of such factors is essential for monitoring the effectiveness of any future plan for combating cholesterol-related risk factors for CVD.
Collapse
Affiliation(s)
- A R Al-Nuaim
- King Khalid University Hospital, College of Science, King Saud University, and Ministry of Health, Riyadh, Saudi Arabia
| | | | | | | | | |
Collapse
|
24
|
Khalil M, Al-Mazrou Y, Abanamy A, Al-Jeffri M, Abdel-Azeem M, Al-Howasi M, Al-Shehry S, Khoja T. National serosurvey of post vaccination poliovirus antibody in Saudi Arabia. Ann Saudi Med 1994; 14:111-3. [PMID: 17589073 DOI: 10.5144/0256-4947.1994.111] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
This is a national seroprevalence study conducted in Saudi Arabai in 1991G to determine postvaccination poliovirus antibody. Two hundred and nine children vaccinated with three oral polio vaccines at three, four, and five months of age were included in the study representing the five main regions in Saudi Arabia. Blood samples were collected at the age of nine months. Cytopathic effect (CPE) neutralization was used to determine the level of polio antibody. A dilution of 1/8th or more was defined as positive. Seventy-nine percent, 88% and 65% of the children were positive for Type 1, Type 2, and Type 3, respetively. Development of a new strategy of polio vaccination is needed.
Collapse
Affiliation(s)
- M Khalil
- Ministry of Health and Suleimania Children's Hospital, Riyadh, Saudi Arabia
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Al-Nuaim A, El-Desouki M, Al-Jurayyan N, Al-Deress A, Ali M, Sulimani R, Al-Habib S, Al-Sakait M, Eissa M, Al-Mazrou Y, Al-Swailem A. Neonatal screening for congenital hypothyroidism: Incidence, imaging, feasability, and difficulties of a nationwide program. Ann Saudi Med 1992; 12:129-34. [PMID: 17589141 DOI: 10.5144/0256-4947.1992.129] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
A pilot project was carried out in Riyadh to study the incidence and pattern of congenital hypothyroidism (CH) among newborn delivered at the Ministry of Health (MOH) hospitals. Cord blood was assayed for thyroid stimulating hormone (TSH). For affected infants, Tc-99m pertechnetate thyroid scintigraphy and perchlorate discharge test (PDT) using I(123) were performed to determine the caused of congenital hypothyroidism. Fifteen affected newborns were diagnosed among 40,000 newborns screened giving an incidence of 1:2666. Tc-99m thyroid scan revealed athyreosis in five infants; the thyroid gland was ectopic in eight and thyroid in two infants. In eight infants thyroid tissue was visualized, PDT was performed and the test was positive in seven cases (two eutopic and five ectopic). We concluded that the incidence of CH was higher compared with other parts of the world. Thyroid scintigraphy has a primary role in the evaluation of infants with congenital hypothyroidism and should be part of the protocol for the screening program. As early initiation of thyroxine therapy will prevent neurological and physical handicaps of the disease, the decision was made to have a nationwide screening program established in Saudi Arabia. The organization and difficulties of the screening program are being discussed.
Collapse
Affiliation(s)
- A Al-Nuaim
- Faculty of Medicine, King Saud University, and Ministry of Health, Riyadh, Saudi Arabia
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|